Southwest Airlines has set up a split fill program, pharmacy benefit manager, health advocacy program, and a cancer resource guide for employees, said Judy Berger, senior manager, benefits planning, Southwest Airlines.
Southwest Airlines has set up a split fill program, pharmacy benefit manager, health advocacy program, and a cancer resource guide for employees, said Judy Berger, senior manager, benefits planning, Southwest Airlines.
Transcript (slightly modified)
What is Southwest Airlines doing in the area of oncology?
We’ve been looking at our data, and we see that oncology is one of the big ticket items. We are self-insured, and we have over 57,000 employees. So, we’ve been looking at the data and we see that we had an area with people being on medications for the first time, and they’d be on the medication for a month, yet they’d only take the pill for maybe 3 days and then they reacted to it. So we put in a split fill program; it’s a benefit to the employee and to the company because they get a 15-day supply, and if it doesn’t work, the employee and the company are only paying for 15 days. If it does work, they get the other 15 days and continue to go on. That’s one area.
We’re also working with our pharmacy benefit manager. They put in a specialty guideline management program which is really looking at the oncology drugs and making sure that the correct drugs are being taken for the correct cancer. There is a prior authorization that’s associated with the program as well.
We also have a new program, called the health advocacy program, and we really started it with our call center employees. We have call center employees, ramp employees, flight attendants, pilots, etc. But, the call enter employees are really sedentary, and they have different issues than other employees. They have diabetes, and they have cancer. So, we’re implementing programs just in those locations to actually test it out. For instance, we found that we have a high prevalence of colon cancer in our Phoenix population, so we started to try out the do it at home colonoscopy kit, and we’re still testing that to see if that works.
The other thing is that we’ve developed a cancer resource guide for employees. You’re just diagnosed with breast cancer, and you don’t know where to go, you don’t know who to turn to, we do have a nurse program where they can turn to them, but there are definitely other resources including their employee assistance program. So, we put that all down on paper so they can read that when they want to read it. In the back of it are carrier-provided questions that an employee might ask when they’re diagnosed with something, such as: what does stage 4 mean? should I get a second opinion? All of those kind of questions, so it can get the employee started on where they should begin.
How are your employees reacting to these programs and benefits?
We’re in the initial stages. So, for instance the cancer resource guide; we sent it out to people who have cancer and who are passed the process of the beginning and we’ve heard comments like, “Gee, I wish I had this in the beginning.” Because then they might have figured out a different doctor to go to, or done a different treatment, or asked different questions. The split fill program, we’re in the first 6 months, so we’re about to evaluate that. We don’t expect a lot of financial gain on that one, but from an employee perspective, they are paying less. So we have heard a few comments on that one. The pharmacy management program, they don’t even know that it’s happening, because it happens in the background. Our cancer resource guide, we hope to see more and more use of it, since it’s just being published now.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More